olprinone has been researched along with Cardiac Diseases in 2 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Milrinone administered through inhalation is an emerging method aimed at specifically reducing pulmonary hypertension without affecting systemic pressures." | 3.80 | A specific and sensitive HPLC-MS/MS micromethod for milrinone plasma levels determination after inhalation in cardiac patients. ( Denault, AY; Gavra, P; Litalien, C; Nguyen, AQ; Theoret, Y; Varin, F, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavra, P | 1 |
| Nguyen, AQ | 1 |
| Theoret, Y | 1 |
| Litalien, C | 1 |
| Denault, AY | 1 |
| Varin, F | 1 |
| Arai, T | 1 |
| Takano, Y | 1 |
| Mizukami, S | 1 |
| Sato, I | 1 |
1 trial available for olprinone and Cardiac Diseases
| Article | Year |
|---|---|
[The effect of olprinone administered after cardio-pulmonary bypass during open heart surgery, evaluated by its plasma concentrations and hemodynamic changes].
Topics: Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Female; Heart Disease | 1999 |
1 other study available for olprinone and Cardiac Diseases
| Article | Year |
|---|---|
A specific and sensitive HPLC-MS/MS micromethod for milrinone plasma levels determination after inhalation in cardiac patients.
Topics: Administration, Inhalation; Cardiopulmonary Bypass; Chemical Fractionation; Chromatography, High Pre | 2014 |